| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 315,564 | 326,558 | 351,273 | 427,192 | | Cost of Revenue | 247,784 | 256,348 | 280,534 | 292,909 | | | Gross Profit | 67,780 | 70,210 | 70,739 | 134,283 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 31,737 | 35,505 | 39,621 | 41,094 | | Non Recurring | 114 | (114) |
-
| (1,010) | | Others | 10,696 | 11,194 | 11,782 | 12,353 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 25,233 | 23,625 | 19,336 | 81,846 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 12,564 | (107) | (303) | (974) | | Earnings Before Interest And Taxes | 37,797 | 23,518 | 19,033 | 80,872 | | Interest Expense | 50,666 | 40,035 | 40,210 | 49,450 | | Income Before Tax | (12,869) | (16,517) | (21,177) | 31,422 | | Income Tax Expense | (7,034) | (5,027) | (7,673) | 13,704 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (5,835) | (11,490) | (13,504) | 17,718 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (5,835) | (11,490) | (13,504) | 17,718 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($5,835) | ($11,490) | ($13,504) | $17,718 |
|
0.31% Nasdaq 
0.05%
Income Statement
